|
LOBBYING REPORT |
Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page
2. Address
Address1 | 8455 Colesville Road |
Address2 | Suite 1100 |
City | Silver Spring |
State | MD |
Zip Code | 20910 |
Country | USA |
3. Principal place of business (if different than line 2)
City |
|
State |
|
Zip Code |
|
Country |
|
|
5. Senate ID# 40021153-48
|
||||||||
|
6. House ID# 398840000
|
TYPE OF REPORT | 8. Year | 2020 |
Q1 (1/1 - 3/31) | Q2 (4/1 - 6/30) | Q3 (7/1 - 9/30) | Q4 (10/1 - 12/31) |
9. Check if this filing amends a previously filed version of this report
10. Check if this is a Termination Report | Termination Date |
|
11. No Lobbying Issue Activity |
INCOME OR EXPENSES - YOU MUST complete either Line 12 or Line 13 | |||||||||
---|---|---|---|---|---|---|---|---|---|
12. Lobbying | 13. Organizations | ||||||||
INCOME relating to lobbying activities for this reporting period was: | EXPENSE relating to lobbying activities for this reporting period were: | ||||||||
|
|
||||||||
|
|
||||||||
Provide a good faith estimate, rounded to the nearest $10,000, of all lobbying related income for the client (including all payments to the registrant by any other entity for lobbying activities on behalf of the client). | 14. REPORTING Check box to indicate expense accounting method. See instructions for description of options. | ||||||||
Method A.
Reporting amounts using LDA definitions only
Method B. Reporting amounts under section 6033(b)(8) of the Internal Revenue Code Method C. Reporting amounts under section 162(e) of the Internal Revenue Code |
Signature | Digitally Signed By: Cole Weintraub |
Date | 7/20/2020 5:57:38 PM |
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code HCR
16. Specific lobbying issues
H.R. 1384 - support for Medicare for All Act
H.R. 6559 - support for Every Worker Protection Act
H.R. 6711 - support for Medical Supply Transparency and Delivery Act
H.R. 6800 - support for HEROES Act
H.R. 6858 - support for COVID19 Emergency Medical Supplies Enhancement Act
H.R. 6906 - Health Care Emergency Guarantee Act
S. 1129 - support for Medicare for All Act
S. 3599 - support for Healthcare Workforce Resilience Act
S. 3627 - support for Medical Supply Transparency and Delivery Act
S. 3677 - support for Every Worker Protection Act
Support for Decontamination and Reuse of N95s
Support for Need for Protections for Nurses in the VA
Support for Accountability and Transparency on Hospital Stimulus Grants
Support for Essential Worker Emergency Task Force Legislation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, President of the U.S., Vice President of the U.S., Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), White House Office, Health & Human Services - Dept of (HHS), Labor - Dept of (DOL), Occupational Safety & Health Administration (OSHA)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amirah |
Sequiera |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code MMM
16. Specific lobbying issues
H.R. 1384 - support for Medicare for All
S. 1129 - support for Medicare for All
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amirah |
Sequiera |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code BUD
16. Specific lobbying issues
H.R. 6711 support for Medical Supply Transparency and Delivery Act
H.R. 6800 support for HEROES Act
H.R. 6909 support for Pandemic Heroes Compensation Act
S. 3627 support for Medical Supply Transparency and Delivery Act
Support for Emergency Funding to the U.S. Postal Service
Support for Accountability and Transparency on Hospital Stimulus Grants
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amirah |
Sequiera |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code LBR
16. Specific lobbying issues
H.R. 6559 - support for Every Worker Protection Act
H.R. 6711 - support for Medical Supply Transparency and Delivery Act
H.R. 6800 - support for HEROES Act
H.R. 6858 - support for COVID19 Emergency Medical Supplies Enhancement Act
H.R. 6909 - support for Pandemic Heroes Compensation Act
S. 3599 - support for Healthcare Workforce Resilience Act
S. 3627 - support for Medical Supply Transparency and Delivery Act
S. 3677 - support for Every Worker Protection Act
Support for Decontamination and Reuse of N95s
Support for Need for Protections for Nurses in the VA
Support for Accountability and Transparency on Hospital Stimulus Grants
Support for Essential Worker Emergency Task Force Legislation
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, White House Office, Centers For Disease Control & Prevention (CDC), Health & Human Services - Dept of (HHS), Executive Office of the President (EOP), Labor - Dept of (DOL), Vice President of the U.S.
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amirah |
Sequiera |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code VET
16. Specific lobbying issues
Support for Defense Production Act Invocation
Support for Protections for Nurses in the VA
17. House(s) of Congress and Federal agencies Check if None
U.S. HOUSE OF REPRESENTATIVES, U.S. SENATE
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amirah |
Sequeira |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.
15. General issue area code DIS
16. Specific lobbying issues
H.R. 6711 support for Medical Supply Transparency and Delivery Act
H.R. 6800 support for HEROES Act
H.R. 6858 support for COVID19 Emergency Medical Supplies Enhancement Act
H.R. 6909 support for Pandemic Heroes Compensation Act
S. 3627 support for Medical Supply Transparency and Delivery Act
Support for Decontamination and Reuse of N95s
S. 3627 support for Medical Supply Transparency and Delivery Act
17. House(s) of Congress and Federal agencies Check if None
U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Executive Office of the President (EOP), Office of the Vice President of the United States, Centers For Disease Control & Prevention (CDC), Natl Institutes of Health (NIH), White House Office, Health & Human Services - Dept of (HHS)
18. Name of each individual who acted as a lobbyist in this issue area
First Name | Last Name | Suffix | Covered Official Position (if applicable) | New |
Amirah |
Sequeira |
|
|
19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None
Information Update Page - Complete ONLY where registration information has changed.
20. Client new address
Address |
|
||||||
City |
|
State |
|
Zip Code |
|
Country |
|
21. Client new principal place of business (if different than line 20)
City |
|
State |
|
Zip Code |
|
Country |
|
22. New General description of client’s business or activities
LOBBYIST UPDATE
23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client
|
|
||||||||
1 |
|
3 |
|
||||||
2 |
|
4 |
|
ISSUE UPDATE
24. General lobbying issue that no longer pertains
|
|
|
|
|
|
|
|
|
AFFILIATED ORGANIZATIONS
25. Add the following affiliated organization(s)
Internet Address:
Name | Address |
Principal Place of Business (city and state or country) |
||||||||||||
| ||||||||||||||
|
26. Name of each previously reported organization that is no longer affiliated with the registrant or client
1 | 2 | 3 |
FOREIGN ENTITIES
27. Add the following foreign entities:
Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership percentage in client | ||||||||||
| ||||||||||||||
|
% |
28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization
1 | 3 | 5 |
2 | 4 | 6 |
CONVICTIONS DISCLOSURE
29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
Lobbyist Name | Description of Offense(s) |